PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Portfolio holdings
AUM
$63M
This Quarter Return
+18.96%
1 Year Return
+35.9%
3 Year Return
+107.34%
5 Year Return
+333.78%
10 Year Return
+1,684.71%
AUM
$65.6M
AUM Growth
+$65.6M
(+0.89%)
Cap. Flow
-$677K
Cap. Flow
% of AUM
-1.03%
Top 10 Holdings %
Top 10 Hldgs %
99.33%
Holding
12
New
2
Increased
2
Reduced
4
Closed
1
Top Buys
| 1 |
Cigna
CI
|
$4.84M |
| 2 |
VRS
Verso Corporation
VRS
|
$2.96M |
| 3 |
Euronet Worldwide
EEFT
|
$1.04M |
| 4 |
Navigator Holdings
NVGS
|
$312K |
Top Sells
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$3.99M |
| 2 |
Newmont
NEM
|
$3.01M |
| 3 |
Bank of New York Mellon
BK
|
$1.18M |
| 4 |
IRIDEX
IRIX
|
$878K |
| 5 |
Wells Fargo
WFC
|
$755K |
Sector Composition
| 1 | Healthcare | 34.81% |
| 2 | Materials | 26.16% |
| 3 | Energy | 25.32% |
| 4 | Financials | 5.42% |
| 5 | Technology | 1.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Newmont
NEM
$81.7B
| $12.1M | 18.37% | 200,000 -50,000 | -20% | -$3.01M |
|
|
2
Navigator Holdings
NVGS
$1.08B
| $11.2M | 17.09% | 1,260,000 +35,000 | +3% | +$312K |
|
|
RETA
3
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $9.97M | 15.2% | 100,000 -40,000 | -29% | -$3.99M |
|
|
4
IRIDEX
IRIX
$22.8M
| $8.03M | 12.24% | 1,190,000 -130,000 | -10% | -$878K |
|
5
Epsilon Energy
EPSN
$129M
| $5.4M | 8.23% | 1,384,461 | – | – |
|
|
VRS
6
DELISTED
Verso Corporation
VRS
| $5.11M | 7.78% | 350,000 +202,690 | +138% | +$2.96M |
|
|
7
Cigna
CI
$80.3B
| $4.84M | 7.37% | +20,000 | New | +$4.84M |
|
8
SPDR S&P 500 ETF Trust
SPY
$658B
| $3.96M | 6.04% | 10,000 | – | – |
|
|
9
Bank of New York Mellon
BK
$74.5B
| $3.55M | 5.42% | 75,000 -25,000 | -25% | -$1.18M |
|
|
10
Euronet Worldwide
EEFT
$3.82B
| $1.04M | 1.58% | +7,500 | New | +$1.04M |
|
11
ATN International
ATNI
$259M
| $442K | 0.67% | 9,000 | – | – |
|
|
12
Wells Fargo
WFC
$263B
| – | – | -25,000 | Closed | -$755K |
|